The association between expression of prolactin receptor and lymph node involvement in triple-negative breast cancer

Author:

Mohamadianamiri Mahdiss1ORCID,Ebrahimi Abdolali2,Farzaneh Farah3,Aklami Majid4,Momeni Mina5,Hajighasem Tannaz5,Shirazi Hossein1,Zeinadini Mohammadreza6ORCID

Affiliation:

1. Firoozgar Clinical Research & Development Center (FCRDC), Iran University of Medical Sciences (IUMS), Tehran, 15937-48711, Iran

2. Department of Pathology, Imam Hossein Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 16177-63141, Iran

3. Preventive Gynecology Research Center (PGRC), Emam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, 16177-63141, Iran

4. Department of Anesthesiology, Akbarabadi Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, 11687-43514, Iran

5. School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, 14496-14535, Iran

6. School of Medicine, Shiraz University of Medical Sciences (SUMS), Fars, 71348-14336, Iran

Abstract

Background: Triple-negative breast cancer (TNBC) is associated with a poor prognosis and requires more aggressive treatment. Aim: The study aimed to evaluate the prophetic role of the prolactin receptor (PRLR) in TNBC stratification. Materials & methods: In a retrospective study, 58 formalin-fixed paraffin-embedded tumor tissues from patients diagnosed with TNBC were examined for PRLR expression using immunohistochemistry. The potential associations between PRLR expression and tumor characteristics were assessed. Result: PRLR expression was negative in 36 (62%) patients and positive in 22 (38%) patients. The number of positive PRLR tumors was significantly higher in patients without lymph node involvement (p = 0.019). Conclusion: PRLR expression was negatively associated with lymph node invasion in TNBC.

Publisher

Future Medicine Ltd

Subject

Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3